Showing results (51-60 of 100) with videos related to

Sort By:
Pageof 10
The Journal of Clinical Psychiatry|May 20, 2024
Effect of Time From Onset of Major Depressive Disorder on the Therapeutic Response to Esmethadone (REL-1017)Clotilde Guidetti, Sara De Martin, Giulia Serra, et al.
World Journal of Gastroenterology|December 6, 2017
Pregnane X receptor and constitutive androstane receptor modulate differently CYP3A-mediated metabolism in early- and late-stage cholestasisDaniela Gabbia, Arianna Dalla Pozza, Laura Albertoni, et al.
The Primary Care Companion for CNS Disorders|February 23, 2023
Subanalysis of Subjective Cognitive Measures From a Phase 2, Double-Blind, Randomized Trial of REL-1017 in Patients With Major Depressive DisorderClotilde Guidetti, Giulia Serra, Luca Pani, et al.
Bioorganic & Medicinal Chemistry|February 26, 2018
Targeting RORs nuclear receptors by novel synthetic steroidal inverse agonists for autoimmune disordersMatteo Dal Prà, Davide Carta, Gyorgy Szabadkai, et al.
Plos One|September 26, 2018
Dexamethasone counteracts hepatic inflammation and oxidative stress in cholestatic rats via CAR activationDaniela Gabbia, Luisa Pozzo, Giorgia Zigiotto, et al.
Vascular Pharmacology|April 12, 2015
NAD(+)-dependent SIRT1 deactivation has a key role on ischemia-reperfusion-induced apoptosisArianna Cattelan, Giulio Ceolotto, Sergio Bova, et al.
Pharmaceuticals (Basel, Switzerland)|July 27, 2022
The N-Methyl-D-Aspartate Receptor Blocker REL-1017 (Esmethadone) Reduces Calcium Influx Induced by Glutamate, Quinolinic Acid, and GentamicinEzio Bettini, Sara De Martin, Andrea Mattarei, et al.
Pageof 10